Register
Forgot your password?

Long-term results of radical correction tetralogy of fallot: what is the problem to be solved?

Authors: Lyapin A.A., Tarasov R.S.

Company: Research Institute for Complex Issues of Cardiovascular Diseases, Kemerovo, Russian Federation

For correspondence:  Sign in or register.

Type:  Reviews


DOI: https://doi.org/10.24022/1997-3187-2021-15-2-146-156

For citation: Anton A. Lyapin, e-mail: Lyapin11@mail.ru

Received / Accepted:  10.06.2021 / 28.06.2021

Keywords: Lyapin A.A., Tarasov R.S. Long-term results of radical correction tetralogy of Fallot: what is the problem to be solved? Creative Cardiology. 2021 15 (2): 146–56 (in Russ.). DOI: 10.24022/1997-3187-2021-15-2-146-156

Full text:  

 

Abstract

Tetralogy of Fallot (TF) is the most common congenital heart defect (CHD) of the cyanotic type. Since the first radical correction was performed in 1954, the tactics of treatment of this CHD has been constantly improving. Currently used TF treatment strategies are associated with a high level of long-term survival (30-year survival ranges from 68.5% to 90.5%). However, after performing a radical correction of TF, the patient may have a number of problems: persistent obstruction of right ventricular (RV) outflow tract, pulmonary artery valve (PAv) regurgitation, ventricular arrhythmias. These pathological phenomena are widespread in this cohort of patients and often require repeated interventions. The often cause of RV dysfunction is a long-term regurgitation on the PAv, as well as its stenosis. Myocardial remodeling acts as the main cause of ventricular and supraventricular arrhythmias, which determines the need for both drug correction and the implementation of interventions aimed at preventing sudden cardiac death in these cohort of patients. The presented review discusses the main pathological conditions that limit the duration and quality of life in patients after radical correction of classical TF, also as possible ways to solve existing postoperative complications

References

  1. Van der Linde D., Konings E.E., Slager M.A., Witsencurg M., Helbing W.A., Tekkenberg M.D. et al. Birth prevalence of congenital heart disease worldwide: a systematic review and meta-analysis. J. Am. Coll. Cardiol. 2011; 58 (21): 2241–7. DOI: 10.1016/j.jacc.2011.08.025
  2. Gatzoulis M.A., Balaji S., Webber S.A., Siu S.C., Hokanson J.S., Poile C. et al. Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot: a multicentre study. Lancet. 2000; 356: 975–81.
  3. Loomba R.S., Buelow M.W., Woods R.K. Complete repair of tetralogy of Fallot in the neonatal versus non-neonatal period: a meta-analysis. Pediatr. Cardiol. 2017; 38 (5): 893–901. DOI: 10.1007/s00246-017-1579-8
  4. Bakhtiary F., Dähnert I., Leontyev S., Schroter T., Hambsch J., Mohr F.W. et al. Outcome and incidence of re-intervention after surgical repair of tetralogy of Fallot. J. Card. Surg. 2013; 28 (1): 59–63. DOI: 10.1111/jocs.12030
  5. Tetralogy of Fallot. Clinical guidelines. Moscow; 2019 (in Russ.). Available at: https://www.Racvs.ru/clinic/clinic-2019 (accessed 17.02.2021).
  6. Cuypers J.A., Menting M.E., Konings E.E., Myrthe E., Opic P., Helbing W.A. et al. Unnatural history of tetralogy of Fallot: prospective follow-up of 40 years after surgical correction. Circulation. 2014; 130 (22): 1944–53. DOI: 10.1161/CIRCULATIONAHA.114.009454
  7. Sarris G.E., Comas J.V., Tobota Z., Maruszewski B. Results of reparative surgery for tetralogy of Fallot: data from the European Association for CardioThoracic Surgery Congenital Database. Eur. J. Cardiothorac. Surg. 2012; 42 (5): 766–74; discussion 774. DOI: 10.1093/ejcts/ezs478
  8. Jacobs J.P., Mayer J.E., Jr, Pasquali S.K., Tweddell J.S., Dearani J.A., Jacobs M.L. et al. The Society of Thoracic Surgeons Congenital Heart Surgery Database: 2018 Update on Outcomes and Quality. Ann. Thorac. Surg. 2018; 105 (3): 680–9. DOI: 10.1016/j.athoracsur.2018.01.001
  9. Jonas R.A. Early primary repair of tetralogy of Fallot. Semin. Thorac. Cardiovasc. Surg. Pediatr. Card. Surg. Annu. 2009; 12: 39–47. DOI: 10.1053/j.pcsu.2009.01.021
  10. Mouws E.M.J.P., de Groot N.M.S., van de Woestijne P.C., Helbing W.A., van Beynum I.M., Bogers J.J.C. et al. Tetralogy of Fallot in the Current Era. Semin. Thorac. Cardiovasc. Surg. 2019; 31 (3): 496–504. DOI: 10.1053/j.semtcvs.2018.10.015
  11. Igisheva L.N., Anikeenko A.A., Shmulevich S.A., Sizova I.N. To the issue of the health comprehensive assessment of children who underwent surgical correction of congenital heart diseases. Complex Issues of Cardiovascular Diseases. 2019; 8 (4S): 42–50 (in Russ.). DOI: 10.17802/2306-1278- 2019-8-4S-42-50
  12. Dijkman P.E., Fioretta E.S., Frese L., Pasqualini F.C., Hoerstrup S.P. Heart valve replacements with regenerative capacity. Transfus. Med. Hemother. 2016; 43 (4): 282–90. DOI: 10.1159/000448181
  13. Redington A.N. Physiopathology of right ventricular failure. Semin. Thorac. Cardiovasc. Surg. Pediatr. Card. Surg. Annu. 2006; 9 (1): 3–10. DOI: 10.1053/j.pcsu.2006.02.005
  14. Bossers G.P.L., Hagdorn Q.A.J., Ploegstra M.J., Borgdorff M.A.J., Sillje H.H.W., Berger R.M.F. et al. Volume load-induced right ventricular dysfunction in animal models: insights in a translational gap in congenital heart disease. Eur. J. Heart Fail. 2018; 20 (4): 808–12. DOI: 10.1002/ejhf.931
  15. Tobler D., Crean A.M., Redington A.N., Oechslin E.N., Silversides C.K., Wald R.M. The left heart after pulmonary valve replacement in adults late after tetralogy of Fallot repair. Int. J. Cardiol. 2012; 160: 165–70.
  16. Geva T., Gauvreau K., Powell A.J., Cecchin F., Rhodes J., Geva J. et al. Randomized trial of pulmonary valve replacement with and without right ventricular remodeling surgery. Circulation. 2010; 122: S201–8.
  17. Hallbergson A., Gauvreau K., Powell A.J., Geva T. Right ventricular remodeling after pulmonary valve replacement: early gains, late losses. Ann. Thorac. Surg. 2015; 99: 660–6.
  18. Gengsakul A., Harris L., Bradley T.J., Webb G.D., Williams W.G., Siu S.C. et al. The impact of pulmonary valve replacement after tetralogy of Fallot repair: a matched comparison. Eur. J. Cardiothorac. Surg. 2007; 32: 462–8.
  19. Stout K.K., Daniels C.J., Aboulhosn J.A., Bozkurt B., Broberg C.S., Colman J.M. et al. 2018 AHA/ACC guideline for the management of adults with congenital heart disease. J. Am. Coll. Cardiol. 2019; 73: e81–192.
  20. Stewart R.D., Backer C.L., Young L., Mavroudis C. Tetralogy of Fallot: results of a pulmonary valvesparing strategy. Ann. Thorac. Surg. 2005; 80 (4): 1431–8; discussion 1438–9. DOI: 10.1016/j.athoracsur.2005.04
  21. Ferraz Cavalcanti P.E., Sá M.P., Santos C.A., Esmeraldo I.M., de Escobar R.R., de Menezes A.M. et al. Pulmonary valve replacement after operative repair of tetralogy of Fallot: meta-analysis and meta-regression of 3,118 patients from 48 studies. J. Am. Coll. Cardiol. 2013; 62 (23): 2227–43. DOI: 10.1016/j.jacc.2013.04.107
  22. Bokma J.P., Geva T., Sleeper L.A., Wald R., Hickey K., Jansen K., Wassall R. et al. A propensity score-adjusted analysis of clinical outcomes after pulmonary valve replacement in tetralogy of Fallot. Heart. 2018; 104 (9): 738–44. DOI: 10.1136/heartjnl2017-312048
  23. Meijer F.M.M., Kies P., Jongbloed M.R.M., Hazekamp M.G., Koolbergen D.R., Blim N.A. et al. Excellent durability of homografts in pulmonary position analysed in a predefined adult group with tetralogy of Fallot. Interact. Cardiovasc. Thorac. Surg. 2019; 28 (2): 279–83. DOI: 10.1093/icvts/ivy242
  24. Diller G.P., Kempny A., Liodakis E., Alonso-Gonzalez R., Inuzuka R., Uebing A. et al. Left ventricular longitudinal function predicts lifethreatening ventricular arrhythmia and death in adults with repaired tetralogy of Fallot. Circulation. 2012; 125 (20): 2440–6. DOI: 10.1161/CIRCULATIONAHA.111.086983
  25. Motta S.E., Lintas V., Fioretta E.S., Hoerstrup S.P., Emmert M.Y. Off-the-shelf tissue engineered heart valves for in situ regeneration: current state, challenges and future directions. Expert Rev. Med. Devices. 2017; 15 (1): 35–45. DOI: 10.1080/17434440.2018.1419865
  26. Jones M.I., Qureshi S.A. Recent advances in transcatheter management of pulmonary regurgitation after surgical repair of tetralogy of Fallot [version 1; peer review: 3 approved]. F1000Research. 2018; 7: 679. DOI: 10.12688/f1000research.14301.1
  27. Chatterjee A., Bajaj N.S., McMahon W.S., Gribbs M.G., White J.S., Mukherjee A. et al. Transcatheter pulmonary valve implantation: a comprehensive systematic review and meta-analyses of observational studies. J. Am. Heart Assoc. 2017; 6 (8): pii: e006432. DOI: 10.1161/JAHA.117.006432
  28. Nordmeyer J., Ewert P., Gewillig M., AlJufan M., Carminati M., Kretschmar O. et al. Acute and midterm outcomes of the post-approval MELODY Registry: a multicentre registry of transcatheter pulmonary valve implantation. Eur. Heart J. 2019; 40 (27): 2255–64. DOI: 10.1093/eurheartj/ehz201
  29. Robichaud B., Hill G., Cohen S., Woods R., Earing M., Frommelt P. et al. Bioprosthetic pulmonary valve endocarditis: Incidence, risk factors, and clinical outcomes. Congenit. Heart Dis. 2018; 13 (5): 734–9. DOI: 10.1111/chd.12639
  30. D'Udekem Y., Galati J.C., Konstantinov I.E., Cheung M.H., Brizard C.P. Intersurgeon variability in long-term outcomes after transatrial repair of tetralogy of Fallot: 25 years' experience with 675 patients. J. Thorac. Cardiovasc. Surg. Elsevier. 2014; 147 (3): 880–6.
  31. Gladman G., McCrindle B.W., Williams W.G., Freedom R.M., Benson L.M. The modified Blalock-Taussig shunt: clinical impact and morbidity in Fallot's tetralogy in the current era. J. Thorac. Cardiovasc. Surg. 1997; 115: 25–30.
  32. Lillehei C.W., Varco R.L., Cohen M., Warden H.E., Patton C., Moller J.H. The first open-heart repairs of ventricular septal defect, atrioventricular communis, and tetralogy of Fallot using extracorporeal circulation by cross-circulation: a 30-year followup. Ann. Thorac. Surg. 1986; 41: 4–21.
  33. Tan C., Soquet J., Brizard C.P., d'Udekem Y. Evolution of residual and recurrent right ventricular outflow tract obstruction after tetralogy of Fallot repair. J. Thorac. Cardiovasc. Surg. 2020; 159 (4): e275–e277. DOI: 10.1016/j.jtcvs.2019.09.190
  34. Valente A.M., Gauvreau K., Assenza G.E., BabuNarayan S., Schreier J., Gatzoulis M.A. et al. Contemporary predictors of death and sustained ventricular tachycardia in patients with repaired tetralogy of Fallot enrolled in the INDICATOR cohort. Heart. 2014; 100 (3): 247–53. DOI: 10.1136/heartjnl-2013-304958
  35. Baumgartner H., Bonhoeffer P., De Groot N.M., de Haan F., Deanfield J.E., Galie N. et al. ESC Guidelines for the management of grown-up congenital heart disease (new version 2010). Eur. Heart J. 2010; 31 (23): 2915–57. DOI: 10.1093/eurheartj/ehq249
  36. Padalino M.A., Cavalli G., Albanese S.B., Napoleone C.P., Guariento A., Cascarano M.T. et al. Long-term outcomes following transatrial versus transventricular repair on right ventricular function in tetralogy of Fallot. J. Card. Surg. 2017; 32 (11): 712–20. DOI: 10.1111/jocs.13236
  37. Dennis M., Moore B., Kotchetkova I., Pressley L., Cordina R., Celermajer D. Adults with repaired tetralogy: low mortality but high morbidity up to middle age. Open Heart. 2017; 4 (1): e000564. DOI: 10.1136/openhrt-2016-000564
  38. Khairy P., Aboulhosn J., Gurvitz M.Z., Opotowsky A.R., Mongeon F.P., Kay J. et al. Arrhythmia burden in adults with surgically repaired tetralogy of Fallot: a multi-institutional study. Circulation. 2010; 122 (9): 868. DOI: 75.10.1161/CIRCULATIONAHA.109.928481
  39. Chandar J.S., Wolff G.S., Garson A. Jr., Kugler J.D., Porter C., Walsh E.P. et al. Ventricular arrhythmias in postoperative tetralogy of Fallot. Am. J. Cardiol. 1990; 65: 655–61.
  40. Garson A. Jr., Randall D.C., Gillette P.C., Smith R.T., Moak J.P., McVey P. et al. Prevention of sudden death after repair of tetralogy of Fallot: treatment of ventricular arrhythmias. J. Am. Coll. Cardiol. 1985; 6: 221–7.
  41. Possner P., Tseng S.Y., Alahdab F., Czosek R.J., Veldtman G.R., Alsaied T. et al. Risk factors for mortality and ventricular tachycardia in patients with repaired tetralogy of Fallot: a systematic review and meta-analysis. Can. J. Cardiol. 2020; 36: 1815–25.
  42. Bokma J.P., Winter M.M., Vehmeijer J.T., Vliegen H.W., van Dijk A.P., van Melle J.P. et al. QRS fragmentation is superior to QRS duration in predicting mortality in adults with tetralogy of Fallot. Heart. 2017; 103: 666–71.
  43. Oosterhof T., Mulder B.J., Vliegen H.W., deRoos A. Corrected tetralogy of Fallot: delayed enhancement in right ventricular outflow tract. Radiology. 2005; 237: 868–71.
  44. Ghonim S., Ernst S., Keegan J., Giannakidis A., Spadotto V., Voges I. et al. Threedimensional late gadolinium enhancement cardiovascular magnetic resonance predicts inducibility of ventricular tachycardia in adults with repaired tetralogy of Fallot. Circ. Arrhythm. Electrophysiol. 2020; 13: 1331–41.
  45. Van Grootel R.W.J., van den Bosch A.E., Baggen V.J.M., Cuypers J.A.A.E., Witsenburg M., Roos-Hesselink J.W. et al. The prognostic value of myocardial deformation in adult patients with corrected tetralogy of Fallot. J. Am. Soc. Echocardiogr. 2019; 32: 866–75.
  46. Cortez D., Barham W., Ruckdeschel E., Sharma N., McCanta A.C., von Alvensleben J. et al. Noninvasive predictors of ventricular arrhythmias in patients with tetralogy of Fallot undergoing pulmonary valve replacement. J. Am. Coll. Cardiol. 2017; 3: 162–70.
  47. Hagdorn Q.A.J., Vos J.D.L., Beurskens N.E.G., van Melle J.P., Berger R.M.F., Wilems T.P. et al. CMR feature tracking left ventricular strain-rate predicts ventricular tachyarrhythmia, but not deterioration of ventricular function in patients with repaired tetralogy of Fallot. Int. J. Cardiol. 2019; 295: 1–6.
  48. Rizk J., Shehu N., Latus H., Martinoff S., Ewert P., Stern H. et al. Magnetic resonance imaging risk factors for ventricular arrhythmias in tetralogy of Fallot. Pediatr. Cardiol. 2020; 41: 862–8.
  49. Zeppenfeld K., Schalij M.J., Bartelings M.M., Tedrow U.B., Koplan B.A., Soejima K. et al. Catheter ablation of ventricular tachycardia after repair of congenital heart disease: electroanatomic identification of the critical right ventricular isthmus. Circulation. 2007; 116: 2241–52.
  50. Kriebel T., Saul J.P., Schneider H., Sigler M., Paul T. Noncontact mapping and radiofrequency catheter ablation of fast and hemodynamically unstable vent-ricular tachycardia after surgical repair of tetralogy of Fallot. J. Am. Coll. Cardiol. 2007; 50: 2162–8.
  51. Kapel G.F., Reichlin T., Wijnmaalen A.P., Piers S.R.D., Holman E.R., Tedrow U.B. et al. Reentry using anatomically determined isthmuses: a curable ventricular tachycardia in repaired congenital heart disease. Circ. Arrhythm. Electrophysiol. 2015; 8: 102–9.
  52. Koyak Z., Harris L., de Groot J.R., Silversides C.K., Oechslin E.N., Bouma B.J. et al. Sudden cardiac death in adult congenital heart disease. Circulation. 2012; 126:.1944–54.
  53. Khairy P., Van Hare G.F., Balaji S., Triedman J.K., Walsh E.P., Warnes C.A. et al. PACES/HRS expert consensus statement on the recognition and management of arrhythmias in adult congenital heart disease. Heart Rhythm. 2014; 11: e102–65.
  54. DeWitt E.S., Triedman J.K., Cecchin F., Mah D.Y., Abrams D.J., Walsh E.P. et al. Time dependence of risks and benefits in pediatric primary prevention implantable cardioverterdefibrillator therapy. Circ. Arrhythm. Electrophysiol. 2014; 7: 1057–63.
  55. Kalaitzidis P., Orwat S., Kempny A., Robert R., Peters B., Sarikouch S. et al. Biventricular dyssynchrony on cardiac magnetic resonance imaging and its correlation with myocardial deformation, ventricular function and objective exercise capacity in patients with repaired tetralogy of Fallot. Int. J. Cardiol. 2018; 264: 53–7. DOI: 10.1016/j.ijcard.2018.04.005
  56. Yim D., Hui W., Larios G., Dragulescu A., GrosseWortmann L., Bijnens B. et al. Quantification of right ventricular electromechanical dyssynchrony in relation to right ventricular function and clinical outcomes in children with repaired tetralogy of Fallot. J. Am. Soc. Echocardiogr. 2018; 31 (7): 822–30. DOI: 10.1016/j.echo.2018.03.012
  57. Koyak Z., de Groot J.R., Krimly A., Mackay T.M., Bouma B.J., Silversides C.K. et al. Cardiac resynchronization therapy in adults with congenital heart disease. Europace. 2018; 20 (2): 315–22. DOI: 10.1093/europace/euw386
  58. Guidelines for the management of adult congenital heart disease: The Task Force for the management of adult congenital heart disease of the European Society of Cardiology (ESC). Eur. Heart J. 2021; 42 (6): 563–645. DOI: 10.1093/eurheartj/ehaa554
  59. Clinical guidelines of Eurasian Association of Cardiologists on diagnosis and treatment of patients with pulmonary hypertension. Moscow; 2019 (in Russ.). Available at: https://cardio-eur.asia (accessed 21.03.2021).

About Authors

  • Anton A. Lyapin, Postgraduate; ORCID
  • Roman S. Tarasov, Dr. Med. Sci., Head of Laboratory of X-ray Endovascular and Reconstructive Cardiovascular Surgery; ORCID

Chief Editor

Leo A. Bockeria, MD, PhD, DSc, Professor, Academician of Russian Academy of Sciences, President of Bakoulev National Medical Research Center for Cardiovascular Surgery


Sort by